Substance | Experimental animal | Tested dosage and time point | Effects | NOAEL LOAELa | Reference |
---|---|---|---|---|---|
PFOS | Rats | 1, 5, and 10 mg/kg BW/day; GD 6 to 15 | Body mass of the maternal animal ↓and lens abnormalities | 5 10 | Gortner [291] |
 | Rats | 5 and 10 mg/kg BW/day; GD 6 to 15 | Weight loss of the maternal animal and developmental toxic effects: birth weight ↓, inner organ abnormalities, delayed ossification, and skeletal anomalies | 1 5 | Wetzel [292] |
 | Rats | 1, 2, 3, 5, and 10 mg/kg BW/day; GD 2 to 21 | Weight gain of the maternal animal ↓; serum T4 and T3 of the maternal animal ↓; at the highest dosage: body weight of the fetus ↓, cleft palate, anasarca, death rate 4 to 6 h after birth ↑; and from 2 mg/kg BW/day: postnatal growth rate, delayed opening of eyes, T4 ↓ | n.r. | |
 | Mice | 1, 5, 10, 15, and 20 mg/kg BW/day; GD 1 to 18 | Delayed opening of eyes and from 5 mg/kg BW/day: liver mass ↑ | n.r. | |
 | Rats | 0.4, 0.8, 1, 1.2, 1.6, and 2 mg/kg BW/day; 6 weeks before mating, during gestation, and up to the fourth day of nursing | From 0.8 mg/kg BW/day: gestation time and viability of the young animals ↓ | n.r. | |
 | Rats | 0.1, 0.4, 1.6, and 3.2 mg/kg BW/day; 42 days before mating, during gestation, and nursing | At highest dosage: gestation time, number of implantation points, and litter size ↓; and at the second-highest dosage (F1): reduced viability, body weight of the newborn, delayed reflexes and physical development, food uptake after weaning ↓ and dosage (F2): birth weight ↓ | 0.1 0.4 | Christian et al. [164] |
 | Rabbits | 0.1, 1, 2.5, and 3.75 mg/kg BW/day; GD 6 to 20 | Weight gain of the maternal animal ↓;and at the second highest dosage: birth weight ↓ and delayed ossification | 0.1 1 1 2.5 | Case et al. [293] |
 | Mice | 1, 10, and 20 mg/kg BW/day; GD 0 to the end of the study | At the highest dosage (maternal animal): weight gain, feed ↓, water uptake ↑, liver mass ↑; body weight of the fetus ↓, enlargement of the neck, skeletal deformity; and newborn weak and inactive, lung atelectasis, aneurism of intracranial arteries, respiratory dysfunction to death | n.r. | Yahia et al. [294] |
 | Leghorn chickens | 1, 2.5, and 5 mg/kg egg; before incubation | No effect on hatching rate, spleen mass ↑, right wings shorter, frequent occurrence of brain asymmetry, immunoglobulin (IgM, IgY) ↓, plasma lysozyme activity ↑; at the highest dosage: liver mass ↑; and at the highest dosage: body weight ↑ | (1 mg/kg egg to 154 ng/g in serum) | Peden-Adams et al. [175] |
 | Mallard ducks and quail | 10, 50, and 150 mg/kg of feed | Viability of the 14-day-old progeny↓; at the lowest dosage: slight increase in incidences of small testes (length); however, spermatogenesis and fertility were not affected | Quail, 10 mg/kg feed | Newsted et al. [177] |
PFOA | Rats | 1, 3, 10, and 30 mg/kg BW/day | Body weight ↓, liver and kidney mass ↑; and at the highest dosage: birth weight ↓, mortality after weaning ↑, delayed puberty | n.r. | |
 | Mice | 1, 3, 5, 10, 20, and 40 mg/kg BW/day; during gestation | Liver enlargement; full-term gestation, viable fetuses, fetus weight, postnatal viability ↓; and growth deficit, delayed opening of eyes, accelerated sexual maturity of male progeny | n.r. | Lau et al. [161] |
 | Mice | 3 to 20 mg/kg BW/day | Liver mass of the maternal animal ↑; body weight gain ↓; and application during GD 7 to 17 and 10 to 17: delayed opening of eyes and growth of coat | n.r. | Wolf et al. [169] |
 | Mice | 5 mg/kg BW/day; GD 1 to 17, 8 to 17, and 12 to 17 | Body weight of young animals ↓ and abnormal development of the nursing process to retarded growth of progeny | n.r. | White et al. [295] |
 | Chickens | 5, 20, 40 mg/kg egg; before incubation | Impaired hatching rate, high prevalence of splayed legs, and chicks with partial or complete loss of yellow pigment in the down | n.r. | Yanai et al. [174] |
PFBS | Rats | 30 to 1, 000 mg/kg | No impairment of fertility or reproduction, no developmental toxic effects aside from a slight delay in onset of puberty, and weight gain in male F1 rats of the group with the highest dosage | n.r. | Lau et al. [115] |
PFHxS | Rats | n.r. | No effect on fertility, reproduction, or viability and growth of the progeny | 10 | |
N-Et-FOSE | Rats | n.r. | Toxic effects similar to those of PFOS, still birth, and mortality in the first three days ↑; in addition, increase in the number of stillbirths and mortality in the F2 generation | n.r. | Christian et al. [164]; Lübker et al. [163] cited in Lau et al. [115] |
PFBA | Mice | 35, 175, and 350 mg/kg BW/day; GD 1 to 17 | No adverse effects in regard to survival rate of the progeny or their postnatal growth, delayed opening of eyes, at the two highest dosages: delayed onset of puberty, and at the highest dosage: loss of complete litter | n.r. | Das et al. [180] |
PFNA | Rats | 1, 3, and 5 mg/kg/day; for 14 days | Cell apoptosis in the testes and imbalance between testosterone and estradiol | n.r. | Feng et al. [183] |
PFDA | Mice | 0.25, 0.5, 1, 2, 4, 8, and 16, 32 mg/kg BW/day; GD 10 to 13 and 0.03, 0.3, 1, 3, 6.4, and 12.8 mg/kg BW/day; GD 6 to 15 | No deformities or other developmental toxic effects; the applied dosages also did not show toxic effects in the maternal animal | n.r. | Harris and Birnbaum [182] |
8:2 FTOH | Rats | n.r. | Only mild effects similar to those caused by PFOA | 200 |